Bizarre Patents
Combination Beverage Container and Spittoon
A combination beverage container and spittoon includes a bottom portion including outer wall and a first inner wall defining a spittoon space.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110311582 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS The present invention provides lipids that are advantageously used in lipid particles for the in vivo delivery of therapeutic agents to cells. In particular, the invention formula (I) provides lipids having the following structure XXXIII wherein: R1 and R 12/22/2011 | |
| 20110237813 | CO-PRECIPITATED SALTS OF FATTY ACIDS A co-salt of a polyunsaturated fatty acid and a non-fatty acid is formed as a precipitate. The co-salt formed is free flowing and does not tend to agglomerate (cake) in storage. The resultant co-salt product will be easy to blend with other products to produce dietary s... | 09/29/2011 |
| 20110237667 | Compositions Containing Diethanol Amine Esterquats The invention relates to compositions containing one or more compounds of the formula (1), wherein R1CO and R2CO are linear or branched saturated acyl groups independent of each other, having 18 to 24 C atoms, and A− is a counter-ion, ... | 09/29/2011 |
| 20110172305 | Endocannabinoids for Enhancing Growth and Development in Infants The present invention relates to a method for promoting infant feeding, growth or development comprising administering to an infant a formula or a pharmaceutical composition comprising an endocannabinoid in an amount sufficient to promote feeding, growth or development.... | 07/14/2011 |
| 20110130456 | Hair Growth Regulating Agent A hair growth regulating agent containing, as an active ingredient, a compound represented by the following formula (I): [wherein R1 represents a substituted or unsubstituted, linear or branched C2 to C25 alkyl group; a group represented by the following formula (II): (... | 06/02/2011 |
| 20100331268 | Nitrated Lipids and Methods of Making and Using Thereof Described herein are nitrated lipids and methods of making and using the nitrated lipids.... | 12/30/2010 |
| 20100324120 | LIPID FORMULATION The invention features a cationic lipid of formula I,
| 12/23/2010 |
| 20100240754 | UNSATURATED FATTY AMINO ACID DERIVATIVES AND USE THEREOF IN DERMAL COSMETOLOGY The present invention relates to drugs consisting of unsaturated fatty amino-acid derivatives of the general formula (I), and to their pharmaceutically acceptable acid addition salts, in which: X is oxygen or NH, Rn are independently hydrogen or a (C1-C6... | 09/23/2010 |
| 20100104629 | CATIONIC LIPIDS AND USES THEREOF Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.... | 04/29/2010 |
| 20100092420 | Preservative Systems Comprising Cationic Surfactants Preservative systems on the basis of cationic surfactants are known i n the art, a typical example of such cationic surfactants is the ethyl ester of the lauramide of arginine monohydrochloride (LAE) (2). Besides the chloride form the corresponding bromide and sulphate ... | 04/15/2010 |
| 20100087656 | Compositions Containing Fatty Acids and/or Derivatives Thereof and a Low Temperature Stabilizer The present invention relates to methods of improving the low temperature storage and performance properties of fatty acids and/or derivatives thereof, as well as compositions containing fatty acids and/or derivatives thereof having superior lower temperature storage an... | 04/08/2010 |
| 20100076055 | Cationic Lipids and Uses Thereof Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.... | 03/25/2010 |
| 20100063135 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF Polyethylene glycol (PEG)-lipid conjugates, polyethylene glycol (PEG)-lipid conjugate based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.... | 03/11/2010 |
| 20100055168 | CATIONIC LIPIDS AND USES THEREOF Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.... | 03/04/2010 |
| 20090285881 | CATIONIC LIPIDS AND USES THEREOF Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.... | 11/19/2009 |
| 20090264525 | FLUOROSURFACTANTS The present invention relates to fatty acid esters of polyols or sulfonated fatty acid esters or sulfonated fatty acid amides containing at least one group Y, where Y stands for CF3—(CH2)a—O—, SF5—, CF3—(C... | 10/22/2009 |
| 20090263407 | Cationic Lipids and Uses Thereof Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.... | 10/22/2009 |
| 20090253924 | Ionic liquids miscible with various polar/non-polar solvents and method of preparing the same Provided are an ionic liquid and a method of preparing the same. The ionic liquid includes at least one type of compound represented by (Cat+)(R′COO−). Here, the Cat+ is a cation selected from the group consisting of quaternary ammon... | 10/08/2009 |
| 20090221705 | OMEGA 3 A process for the preparation of a water soluble unsaturated fatty acid salt from a crude composition comprising at least one non-water soluble or sparingly water soluble unsaturated fatty acid or salt thereof, said process comprising: adding to said crude composition i... | 09/03/2009 |
| 20090137515 | ABUSE-RESISTANT AMPHETAMINE PRODRUGS The invention describes compounds, compositions, and methods of using the same comprising a chemical moiety covalently attached to amphetamine. These compounds and compositions are useful for reducing or preventing abuse and overdose of amphetamine. These compounds and ... | 05/28/2009 |
| 20090137677 | ABUSE-RESISTANT AMPHETAMINE PRODRUGS The invention describes compounds, compositions, and methods of using the same comprising a chemical moiety covalently attached to amphetamine. These compounds and compositions are useful for reducing or preventing abuse and overdose of amphetamine. These compounds and ... | 05/28/2009 |
| 20080014253 | Lipid-Based Drug Delivery Systems Containing Unnatural Phospholipase A2 Degradable Lipid Derivatives and the Therapeutic Uses Thereof The present invention relates to a lipid-based drug delivery system for administration of a lysolipid derivative present in a prodrug from, said prodrug furthermore being a substrate for extracellular phospholipase A2 to the extent that an organic radical can be hydroly... | 01/17/2008 |
| 20070204764 | COMPOUNDS AND METHODS FOR REDUCING WATER CONTENT IN CEMENTITIOUS MIXTURES Compounds for reducing water content in cementitious mixtures selected from an amphoteric, an alkyl polyglycoside, an ester, a triglyceride derivative, and mixtures thereof are provided. Methods are also provided for reducing water content in cementitious mixtures. ... | 09/06/2007 |
| 20060205815 | Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition The present invention provides compounds of formula I described herein. The present invention also provides a method of treating a cognitive dysfunction in a mammal. The method includes administering to the mammal an effective amount of a compound of formula I described... | 09/14/2006 |
| 20050176815 | Anti-inflammatory nitro-and thia-fatty acids The present invention relates to compounds of the general formula: NO2-A-B wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 carbon atoms and B is (CH2)n(COOH)m in which n is an integer from 0 to 2 and m is an... | 08/11/2005 |
| 20050176817 | Anti-inflammatory nitro- and thia- fatty acids The present invention relates to compounds of the general formula: NO2-A-B wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 carbon atoms and B is (CH2)n(COOH)m in which n is an integer from 0 to 2 and m is an... | 08/11/2005 |
| 20050176816 | Anti-inflammatory nitro- and thia-fatty acids The present invention relates to compounds of the general formula: NO2-A-B wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 carbon atoms and B is (CH2)n(COOH)m in which n is an integer from 0 to 2 and m is an... | 08/11/2005 |
| 20050118248 | Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof Amphiphilic derivatives composed of at least one fatty acid chain are derived from natural vegetable oils such as vernonia oil, lesquerella oil and castor oil, in which the several reactive groups such as epoxy, hydroxy and double bonds can be modified to polar and ioni... | 06/02/2005 |
